Increase in Valproic Acid Levels During Riluzole Treatment in an Adolescent with Autism

Aman MG , Lam KS , Van Bourgondien ME . Medication patterns in patients with autism: Temporal, regional, and demographic influences. J Child Adolesc Psychopharmacol, 15:116–126. 2005.

Chalfant AM , Rapee R , Carroll L . Treating anxiety disorders in children with high functioning autism spectrum disorders: A controlled trial. J Autism Dev Disord, 37:1842–1857. 2007.

Coric V , Taskiran S , Pittenger C , Wasylink S , Mathalon DH , Valentine G , Saksa J , Wu YT , Gueorguieva R , Sanacora G , Malison RT , Krystal JH . Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: An open-label trial. Biol Psychiatry, 58:424–428. 2005.

Gordon C , State R , Nelson J , Hamburger S , Rapoport J . A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry, 50:441–447. 1993.

Gordon CT , Rapoport JL , Hamburger SD , State RC , Mannheim GB . Differential response of seven subjects with autistic disorder to clomipramine and desipramine. Am J Psychiatry, 149:363–366. 1992.

Grant P , Lougee L , Hirschtritt M , Swedo SE . An open-label trial of riluzole, a glutamate antagonist, in children with treatment-resistant obsessive-compulsive disorder. J Child Adolesc Psychopharmacol, 17:761–767. 2007.

Hollander E , Phillips A , Chaplin W , Zagursky K , Novotny S , Wasserman S , Iyengar R . A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology, 30:582–589. 2005.

Hollander E , Soorya L , Wasserman S , Esposito K , Chaplin W , Anagnostou E . Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol, 9:209–213. 2006.

Kiang TK , Ho PC , Anari MR , Tong V , Abbott FS , Chang TK . Contribution of CYP2C9, CYP2A6, and CYP2B6 to valproic acid metabolism in hepatic microsomes from individuals with the CYP2C9*1/*1 genotype. Toxicol Sci, 94:261–271. 2006.

King BH , McCracken JT , Sikich L . Treatment of Repetitive Behavior in Autism Spectrum Disorders: Results of the NIH STAART Psychopharmacology Network Trial. American Academy of Child and Adolescent Psychiatry Annual Meeting: Chicago, 2008.

Lehmkuhl HD , Storch EA , Bodfish JW , Geffken GR . Brief report: Exposure and response prevention for obsessive compulsive disorder in a 12-year-old with autism. J Autism Dev Disord, 38:977–981. 2008.

McCracken JT , McGough J , Shah B , Cronin P , Hong D , Aman MG , Arnold LE , Lindsay R , Nash P , Hollway J , McDougle CJ , Posey D , Swiezy N , Kohn A , Scahill L , Martin A , Koenig K , Volkmar F , Carroll D , Lancor A , Tierney E , Ghuman J , Gonzalez NM , Grados M , Vitiello B , Ritz L , Davies M , Robinson J , McMahon D . Risperidone in children with autism and serious behavioral problems. N Engl J Med, 347:314–321. 2002.

McDougle C , Naylor S , Cohen D , Volkmar F , Heninger G , Price L . A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry, 53:1001–1008. 1996.

McDougle CJ , Kresch LE , Posey DJ . Repetitive thoughts and behavior in pervasive developmental disorders: Treatment with serotonin reuptake inhibitors. J Autism Dev Disord, 30:427–435. 2000.

McDougle CJ , Scahill L , Aman MG , McCracken JT , Tierney E , Davies M , Arnold LE , Posey DJ , Martin A , Ghuman JK , Shah B , Chuang SZ , Swiezy NB , Gonzalez NM , Hollway J , Koenig K , McGough JJ , Ritz L , Vitiello B . Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry, 162:1142–1148. 2005.

Ooi YP , Lam CM , Sung M , Tan WT , Goh TJ , Fung DS , Pathy P , Ang RP , Chua A . Effects of cognitive-behavioural therapy on anxiety for children with high-functioning autistic spectrum disorders. Singapore Med J, 49:215–220. 2008.

Patsalos PN , Perucca E . Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. Lancet Neurol, 2:473–481. 2003.

Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavioral therapy, sertraline, their combination for children, adolescents with obsessive-compulsive disorder. The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA, 292:1969–1976. 2004.

Pittenger C , Kelmendi B , Wasylink S , Bloch MH , Coric V . Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: A series of 13 cases, with long-term follow-up. J Clin Psychopharmacol, 28:363–367. 2008.

Reaven J , Hepburn S . Cognitive-behavioral treatment of obsessive-compulsive disorder in a child with Asperger syndrome: A case report. Autism, 7:145–164. 2003.

Sanderink GJ , Bournique B , Stevens J , Petry M , Martinet M . Involvement of human CYP1A isoenzymes in the metabolism and drug interactions of riluzole in vitro. J Pharmacol Exp Ther, 282:1465–1472. 1997.

Scahill L , McDougle CJ , Williams SK , Dimitropoulos A , Aman MG , McCracken JT , Tierney E , Arnold LE , Cronin P , Grados M , Ghuman J , Koenig K , Lam KS , McGough J , Posey DJ , Ritz L , Swiezy NB , Vitiello B . Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry, 45:1114–1123. 2006.

Soorya L , Kiarashi J , Hollander E . Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders. Child Adolesc Psychiatr Clin N Am, 17:753–771 viii. 2008.

van Kan HJ , Groeneveld GJ , Kalmijn S , Spieksma M , van den Berg LH , Guchelaar HJ . Association between CYP1A2 activity and riluzole clearance in patients with amyotrophic lateral sclerosis. Br J Clin Pharmacol, 59:310–313. 2005.

Wood JJ , Drahota A , Sze K , Har K , Chiu A , Langer DA . Cognitive behavioral therapy for anxiety in children with autism spectrum disorders: A randomized, controlled trial. J Child Psychol Psychiatry, 50:224–234. 2009.